Proposed Data Collection Submitted for Public Comment and Recommendations, 53309-53312 [2021-20846]

Download as PDF 53309 Federal Register / Vol. 86, No. 184 / Monday, September 27, 2021 / Notices Centers for Disease Control and Prevention (CDC). Background and Brief Description Cigarette smoking is the leading preventable cause of premature death and disability in our nation. Each year more than 480,000 deaths occur as the result of cigarette smoking-related diseases. The CDC’s Office on Smoking and Health (OSH) is the lead federal agency for comprehensive tobacco prevention and control. Since 1986, as required by the Comprehensive Smoking Education Act (CSEA) of 1984, which amended the Federal Cigarette Labeling and Advertising Act (FCLAA), 15 U.S.C. 1335a, CDC has collected information about the ingredients used in cigarette products. HHS has delegated responsibility for implementing the required information collection to CDC’s OSH. Respondents are commercial cigarette manufacturers, packagers, or importers (or their representatives), who Attention: FCLAA Program Manager, Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Highway NE, MS S107–7, Atlanta, GA 30341–3717. Upon receipt and verification of the annual ingredient report, CDC issues a Certificate of Compliance to the respondent. As deemed appropriate by the Secretary of HHS, HHS is authorized to use the information to report to Congress the health effects of ingredients, research activities related to the health effects of ingredients, and other information that the Secretary determines to be of public interest. There are no costs to respondents other than their time. The total estimated annualized burden hours are 358. OMB approval is requested for three years. are required by FCLAA to submit ingredient reports to HHS on an annual basis. Respondents are not required to submit specific forms; however, they are required to submit a list of all ingredients used in their products. CDC requires the ingredient report to be submitted by chemical name and Chemical Abstract Service (CAS) Registration Number, consistent with accepted reporting practices for other companies currently required to report ingredients added to other consumer products. The information collected is subject to strict confidentiality provisions. Ingredient reports are due annually on March 31. Information is submitted to CDC by mailing or faxing a written report on the respondent’s letterhead. All faxed lists should be followed up with a mailed original. Electronic mail submissions are not accepted. Mail Annual Ingredient Submissions to ESTIMATED ANNUALIZED BURDEN HOURS Number of responses per respondent Average burden per response (in hours) Total burden (in hours) Form name Business Entities ............................... N/A ................................................... 55 1 6.5 358 Total ........................................... ........................................................... ........................ ........................ ........................ 358 Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2021–20844 Filed 9–24–21; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–21–0666; Docket No. CDC–2021– 0100] Proposed Data Collection Submitted for Public Comment and Recommendations Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on SUMMARY: VerDate Sep<11>2014 18:08 Sep 24, 2021 Jkt 253001 a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled National Healthcare Safety Network (NHSN). NHSN is the nation’s most widely used healthcare-associated infection tracking system, providing facilities, states, regions, and the nation with data needed to identify problem areas, measure progress of prevention efforts, and ultimately eliminate healthcare-associated infections. DATES: CDC must receive written comments on or before November 26, 2021. change, all relevant comments to Regulations.gov. Please note: Submit all comments through the Federal eRulemaking portal (regulations.gov) or by U.S. mail to the address listed above. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H21–8, Atlanta, Georgia 30329; phone: 404–639–7570; Email: omb@ cdc.gov. You may submit comments, identified by Docket No. CDC–2020– 0100 by any of the following methods: • Federal eRulemaking Portal: Regulations.gov. Follow the instructions for submitting comments. • Mail: Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H21–8, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and Docket Number. CDC will post, without SUPPLEMENTARY INFORMATION: ADDRESSES: AGENCY: lotter on DSK11XQN23PROD with NOTICES1 Number of respondents Type of respondents PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of E:\FR\FM\27SEN1.SGM 27SEN1 53310 Federal Register / Vol. 86, No. 184 / Monday, September 27, 2021 / Notices previously approved information collection before submitting the collection to the OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. The OMB is particularly interested in comments that will help: 1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; 2. Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; 3. Enhance the quality, utility, and clarity of the information to be collected; 4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submissions of responses; and 5. Assess information collection costs. lotter on DSK11XQN23PROD with NOTICES1 Proposed Project National Healthcare Safety Network (NHSN) (OMB Control No. 0920–0666, Exp. 12/31/2023)—Revision—National Center for Emerging and Zoonotic Infection Diseases (NCEZID), Centers for Disease Control and Prevention (CDC). Background and Brief Description The Division of Healthcare Quality Promotion (DHQP), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC) collects data from healthcare facilities in the National Healthcare Safety Network (NHSN) (OMB Control Number 0920– 0666). NHSN provides facilities, states, regions, and the nation with data necessary to identify problem areas, measure the progress of prevention efforts, and ultimately eliminate healthcare-associated infections (HAIs) nationwide. NHSN allows healthcare facilities to track blood safety errors and various healthcare-associated infection prevention practice methods such as healthcare personnel influenza vaccine status and corresponding infection control adherence rates. NHSN currently has six components: Patient Safety (PS), Healthcare Personnel Safety (HPS), Biovigilance (BV), Long-Term Care Facility (LTCF), Outpatient Procedure (OPC), and the Dialysis Component. NHSN’s planned VerDate Sep<11>2014 18:08 Sep 24, 2021 Jkt 253001 Neonatal Component is expected to launch during the winter of 2021, and will focus on premature neonates and the healthcare-associated events that occur as a result of their prematurity. This component will be released with one module, which includes Late OnsetSepsis (LOS) and Meningitis. LOS and Meningitis are common complications of extreme prematurity. These infections result in a prolongation of hospital stay, increased cost, and risk of morbidity and mortality. The data for this module will be electronically submitted, allowing more hospital personnel to be available to care for patients and reducing annual burden across healthcare facilities. Additionally, LOS data will be utilized for prevention initiatives. Data reported under the Patient Safety Component are used to determine the magnitude of the healthcare-associated adverse events and trends in the rates of events, in the distribution of pathogens, and in the adherence to prevention practices. Data will help detect changes in the epidemiology of adverse events resulting from new medical therapies and changing patient risks. Additionally, reported data is being used to describe the epidemiology of antimicrobial use and resistance, and to better understand the relationship of antimicrobial therapy to this rising problem. Under the Healthcare Personnel Safety Component (HPS), protocols and data on events—both positive and adverse—are used to determine; (1) the magnitude of adverse events in healthcare personnel, and (2) compliance with immunization and sharps injuries safety guidelines. The Biovigilance (BV) Component collects data on adverse reactions and incidents associated with blood transfusions. Data is reported and analyzed to provide national estimates of adverse reactions and incidents. Under the Long-Term Care Facility (LTCF) Component, data is captured from skilled nursing facilities. Reporting methods under the LTCF component have been created by using forms from the PS Component as a model with modifications to specifically address the specific characteristics of LTCF residents and the unique data needs of these facilities reporting into NHSN. The Respiratory Tract Infection Form (RTI), titled ‘‘Denominators for Healthcare Associated Infections (HAIs): Respiratory Tract Infections,’’ will not to be used by NHSN users, but rather as part of an EIP project with 4 EIP sites. The purpose of this form is to allow testing prior to introducing a new module and forms to NHSN users. The PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 CDC’s Epidemiology Research & Innovations Branch (ERIB) team will use the form to perform field testing of variables to explore the utilization, applicability, and data collection burden associated with these variables. This process will inform areas of improvement prior to incorporating the new module, including protocol, forms, and instructions into NHSN. The Dialysis Component offers a simplified user interface for dialysis users to streamline their data entry and analyses processes, as well as provide options for expanding in the future to include dialysis surveillance in settings other than outpatient facilities. The Outpatient Procedure Component (OPC) gathers data on the impact of infections and outcomes related to operative procedures performed in Ambulatory Surgery Centers (ASCs). The OPC is used to monitor two event types: Same Day Outcome Measures and Surgical Site Infections (SSIs). NHSN has increasingly served as the operating system for HAI reporting compliance through legislation established by the states. As of April 2020, 36 states, the District of Columbia and the City of Philadelphia, Pennsylvania have opted to use NHSN as their primary system for mandated reporting. Reporting compliance is completed by healthcare facilities in their respective jurisdictions, with emphasis on those states and municipalities acquiring varying consequences for failure to use NHSN. Additionally, healthcare facilities in five U.S. territories (Puerto Rico, American Samoa, the U.S. Virgin Islands, Guam, and the Northern Mariana Islands) are voluntarily reporting to NHSN. Additional territories are projected to follow with similar use of NHSN for reporting purposes. NHSN’s data is used to aid in the tracking of HAIs and guide infection prevention activities/practices that protect patients. The Centers for Medicare and Medicaid Services (CMS)and other payers use these data to determine incentives for performance at healthcare facilities across the U.S. and surrounding territories, and members of the public may use some protected data to inform their selection among available providers. Each of these parties is dependent on the completeness and accuracy of the data. CDC and CMS work closely and are fully committed to ensuring complete and accurate reporting, which are critical for protecting patients and guiding national, state, and local prevention priorities. CMS collects some HAI data and healthcare personnel influenza vaccination summary data, E:\FR\FM\27SEN1.SGM 27SEN1 53311 Federal Register / Vol. 86, No. 184 / Monday, September 27, 2021 / Notices has collaborated with CMS on a voluntary National Nursing Home Quality Collaborative, which focuses on recruiting nursing homes to report HAI data to NHSN and to retain their continued participation. NHSN was previously approved in December 2020 for 1,321,991 burden hours. The proposed changes in this new ICR include revisions to 10 data collection forms and no new forms for a total of 86 proposed data collection forms. In this Revision, CDC requests OMB approval for an estimated 1,718,591 annual burden hours. ambulatory surgery centers. Facilities report HAI data and healthcare personnel influenza vaccination summary data to CMS via NHSN as part of CMS’s quality reporting programs to receive full payment. Still, many healthcare facilities, even in states without HAI reporting legislation, submit limited HAI data to NHSN voluntarily. NHSN’s data collection updates continue to support the incentive programs managed by CMS. For example, survey questions support requirements for CMS’ quality reporting programs. Additionally, CDC which is done on a voluntary basis as part of its Fee-for-Service Medicare quality reporting programs, while others may report data required by a federal mandate. Facilities that fail to report quality measure data are subject to partial payment reduction in the applicable Medicare Fee-for-Service payment system. CMS links their quality reporting to payment for Medicare-eligible acute care hospitals, inpatient rehabilitation facilities, longterm acute care facilities, oncology hospitals, inpatient psychiatric facilities, dialysis facilities, and ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents lotter on DSK11XQN23PROD with NOTICES1 Form number & name 57.100 NHSN Registration Form .................................................................. 57.101 Facility Contact Information .............................................................. 57.103 Patient Safety Component—Annual Hospital Survey ....................... 57.104 Facility Administrator Change Request Form ................................... 57.105 Group Contact Information ................................................................ 57.106 Patient Safety Monthly Reporting Plan ............................................. 57.108 Primary Bloodstream Infection (BSI) ................................................. 57.111 Pneumonia (PNEU) ........................................................................... 57.112 Ventilator-Associated Event .............................................................. 57.113 Pediatric Ventilator-Associated Event (PedVAE) .............................. 57.114 Urinary Tract Infection (UTI) ............................................................. 57.115 Custom Event .................................................................................... 57.116 Denominators for Neonatal Intensive Care Unit (NICU) ................... 57.117 Denominators for Specialty Care Area (SCA)/Oncology (ONC) ...... 57.118 Denominators for Intensive Care Unit (ICU)/Other locations (not NICU or SCA) .............................................................................................. 57.120 Surgical Site Infection (SSI) .............................................................. 57.121 Denominator for Procedure ............................................................... 57.122 HAI Progress Report State Health Department Survey ................... 57.123 Antimicrobial Use and Resistance (AUR)—Microbiology Data Electronic Upload Specification Tables .............................................................. 57.124 Antimicrobial Use and Resistance (AUR)—Pharmacy Data Electronic Upload Specification Tables .............................................................. 57.125 Central Line Insertion Practices Adherence Monitoring ................... 57.126 MDRO or CDI Infection Form ........................................................... 57.127 MDRO and CDI Prevention Process and Outcome Measures Monthly Monitoring ....................................................................................... 57.128 Laboratory-identified MDRO or CDI Event ....................................... 57.129 Adult Sepsis ...................................................................................... 57.135 Late Onset Sepsis/Meningitis Denominator Form: Data Table for monthly electronic upload ............................................................................ 57.136 Late Onset Sepsis/Meningitis Event Form: Data Table for Monthly Electronic Upload ......................................................................................... 57.137 Long-Term Care Facility Component—Annual Facility Survey ........ 57.138 Laboratory-identified MDRO or CDI Event for LTCF ........................ 57.139 MDRO and CDI Prevention Process Measures Monthly Monitoring for LTCF ....................................................................................................... 57.140 Urinary Tract Infection (UTI) for LTCF .............................................. 57.141 Monthly Reporting Plan for LTCF ..................................................... 57.142 Denominators for LTCF Locations .................................................... 57.143 Prevention Process Measures Monthly Monitoring for LTCF ........... 57.150 LTAC Annual Survey ........................................................................ 57.151 Rehab Annual Survey ....................................................................... 57.200 Healthcare Personnel Safety Component Annual Facility Survey ... 57.204 Healthcare Worker Demographic Data ............................................. 57.205 Exposure to Blood/Body Fluids ......................................................... 57.206 Healthcare Worker Prophylaxis/Treatment ....................................... 57.207 Follow-Up Laboratory Testing ........................................................... 57.210 Healthcare Worker Prophylaxis/Treatment-Influenza ....................... 57.300 Hemovigilance Module Annual Survey ............................................. 57.301 Hemovigilance Module Monthly Reporting Plan ............................... 57.303 Hemovigilance Module Monthly Reporting Denominators ................ 57.305 Hemovigilance Incident ..................................................................... VerDate Sep<11>2014 18:08 Sep 24, 2021 Jkt 253001 PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 Number of responses per respondent Avg. burden per response (hours) Total burden (hours) 2,000 2,000 6,765 800 1,000 7,821 5,775 1,800 5,463 334 6,000 600 1,100 500 1 1 1 1 1 12 5 2 8 1 5 91 12 12 5/60 10/60 90/60 5/60 5/60 15/60 38/60 30/60 28/60 30/60 20/60 35/60 4/60 5/60 167 333 10,148 67 83 23,463 18,288 1,800 20,395 167 10,000 31,850 880 500 5,500 6,000 6,000 55 60 9 602 1 5/60 35/60 10/60 28/60 27,500 31,500 602,000 26 2,500 12 5/60 2,500 2,500 500 720 12 213 11 5/60 25/60 30/60 2,500 44,375 3,960 5,500 4,800 50 29 79 250 15/60 20/60 25/60 39,875 126,400 5,208 300 6 5/60 150 300 17,700 1,998 6 1 24 5/60 120/60 20/60 150 35,400 15,984 1,998 339 2011 339 130 620 1,340 50 50 50 50 50 50 500 500 500 500 12 36 12 12 12 1 1 1 200 50 30 50 50 1 12 12 10 20/60 35/60 5/60 35/60 5/60 82/60 82/60 480/60 20/60 60/60 15/60 15/60 10/60 85/60 60/60 70/60 10/60 7,992 7,119 2,011 2,373 130 847 1,831 400 3,333 2,500 375 625 417 708 6,000 7,000 833 E:\FR\FM\27SEN1.SGM 27SEN1 53312 Federal Register / Vol. 86, No. 184 / Monday, September 27, 2021 / Notices ESTIMATED ANNUALIZED BURDEN HOURS—Continued Number of respondents Form number & name 57.306 Hemovigilance Module Annual Survey—Non-acute care facility ...... 57.307 Hemovigilance Adverse Reaction—Acute Hemolytic Transfusion Reaction ....................................................................................................... 57.308 Hemovigilance Adverse Reaction—Allergic Transfusion Reaction .. 57.309 Hemovigilance Adverse Reaction—Delayed Hemolytic Transfusion Reaction ....................................................................................................... 57.310 Hemovigilance Adverse Reaction—Delayed Serologic Transfusion Reaction ....................................................................................................... 57.311 Hemovigilance Adverse Reaction—Febrile Non-hemolytic Transfusion Reaction ............................................................................................ 57.312 Hemovigilance Adverse Reaction—Hypotensive Transfusion Reaction ................................................................................................................ 57.313 Hemovigilance Adverse Reaction—Infection .................................... 57.314 Hemovigilance Adverse Reaction—Post Transfusion Purpura ........ 57.315 Hemovigilance Adverse Reaction—Transfusion Associated Dyspnea ............................................................................................................... 57.316 Hemovigilance Adverse Reaction—Transfusion Associated Graft vs. Host Disease .......................................................................................... 57.317 Hemovigilance Adverse Reaction—Transfusion Related Acute Lung Injury ................................................................................................... 57.318 Hemovigilance Adverse Reaction—Transfusion Associated Circulatory Overload ......................................................................................... 57.319 Hemovigilance Adverse Reaction—Unknown Transfusion Reaction 57.320 Hemovigilance Adverse Reaction—Other Transfusion Reaction ..... 57.400 Outpatient Procedure Component—Annual Facility Survey ............. 57.401 Outpatient Procedure Component—Monthly Reporting Plan ........... 57.402 Outpatient Procedure Component Same Day Outcome Measures 57.403 Outpatient Procedure Component—Monthly Denominators for Same Day Outcome Measures .................................................................... 57.404 Outpatient Procedure Component—SSI Denominator ..................... 57.405 Outpatient Procedure Component—Surgical Site (SSI) Event ......... 57.500 Outpatient Dialysis Center Practices Survey .................................... 57.501 Dialysis Monthly Reporting Plan ....................................................... 57.502 Dialysis Event .................................................................................... 57.503 Denominator for Outpatient Dialysis ................................................. 57.504 Prevention Process Measures Monthly Monitoring for Dialysis ....... 57.505 Dialysis Patient Influenza Vaccination .............................................. 57.506 Dialysis Patient Influenza Vaccination Denominator ........................ 57.507 Home Dialysis Center Practices Survey ........................................... Weekly Healthcare Personnel Influenza Vaccination Cumulative Summary for Non-Long-Term Care Facilities ............................................................... Weekly Healthcare Personnel Influenza Vaccination Cumulative Summary for Long-Term Care Facilities ...................................................................... Weekly Resident Influenza Vaccination Cumulative Summary for Long-Term Care Facilities .............................................................................................. Annual Healthcare Personnel Influenza Vaccination Summary ...................... Total .......................................................................................................... Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2021–20846 Filed 9–24–21; 8:45 am] lotter on DSK11XQN23PROD with NOTICES1 BILLING CODE 4163–18–P 35/60 292 500 500 4 4 20/60 20/60 667 667 500 1 20/60 167 500 2 20/60 333 500 4 20/60 667 500 500 500 1 1 1 20/60 20/60 20/60 167 167 167 500 1 20/60 167 500 1 20/60 167 500 1 20/60 167 500 500 500 700 700 200 2 1 1 1 12 1 20/60 20/60 20/60 10/60 15/60 40/60 333 167 167 117 2,100 133 200 700 700 7,200 7,200 7,200 7,200 1,730 615 615 430 400 100 5 1 12 30 30 12 50 5 1 40/60 40/60 40/60 12/60 5/60 25/60 10/60 75/60 10/60 10/60 30/60 53,333 46,667 2,333 1,440 7,200 90,000 36000 25,950 5,125 513 215 125 52 60/60 6,500 1,200 52 60/60 62,400 2,500 5,000 52 1 60/60 120/60 130,000 10,000 ........................ ........................ ........................ 1,718,591 Centers for Disease Control and Prevention Solicitation of Nominations for Appointment to the Clinical Laboratory Improvement Advisory Committee (CLIAC) Notice. The Centers for Disease Control and Prevention (CDC) is seeking nominations for membership on the CLIAC. The CLIAC consists of 20 experts including the Chair, represents 18:08 Sep 24, 2021 Jkt 253001 PO 00000 Frm 00051 Fmt 4703 Total burden (hours) 1 SUMMARY: VerDate Sep<11>2014 Avg. burden per response (hours) 500 DEPARTMENT OF HEALTH AND HUMAN SERVICES ACTION: Number of responses per respondent Sfmt 4703 a diverse membership across laboratory specialties, professional roles (laboratory management, technical specialists, physicians, nurses) and practice settings (academic, clinical, public health), and includes a consumer representative. DATES: Nominations for membership on CLIAC must be received no later than March 1, 2022. Packages received after this time will not be considered for the current membership cycle. ADDRESSES: All nominations should be mailed to Nancy Anderson, MMSc, MT(ASCP), CLIAC Secretary, Senior Advisor for Clinical Laboratories, Division of Laboratory Systems, Center E:\FR\FM\27SEN1.SGM 27SEN1

Agencies

[Federal Register Volume 86, Number 184 (Monday, September 27, 2021)]
[Notices]
[Pages 53309-53312]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-20846]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-21-0666; Docket No. CDC-2021-0100]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies the opportunity to comment on a proposed and/or 
continuing information collection, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on a proposed 
information collection project titled National Healthcare Safety 
Network (NHSN). NHSN is the nation's most widely used healthcare-
associated infection tracking system, providing facilities, states, 
regions, and the nation with data needed to identify problem areas, 
measure progress of prevention efforts, and ultimately eliminate 
healthcare-associated infections.

DATES: CDC must receive written comments on or before November 26, 
2021.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2020-
0100 by any of the following methods:
     Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, Mailstop H21-8, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to Regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (regulations.gov) or by U.S. mail to the address listed above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, Mailstop H21-8, Atlanta, Georgia 30329; phone: 404-639-7570; 
Email: [email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of

[[Page 53310]]

previously approved information collection before submitting the 
collection to the OMB for approval. To comply with this requirement, we 
are publishing this notice of a proposed data collection as described 
below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected;
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses; and
    5. Assess information collection costs.

Proposed Project

    National Healthcare Safety Network (NHSN) (OMB Control No. 0920-
0666, Exp. 12/31/2023)--Revision--National Center for Emerging and 
Zoonotic Infection Diseases (NCEZID), Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    The Division of Healthcare Quality Promotion (DHQP), National 
Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers 
for Disease Control and Prevention (CDC) collects data from healthcare 
facilities in the National Healthcare Safety Network (NHSN) (OMB 
Control Number 0920-0666). NHSN provides facilities, states, regions, 
and the nation with data necessary to identify problem areas, measure 
the progress of prevention efforts, and ultimately eliminate 
healthcare-associated infections (HAIs) nationwide. NHSN allows 
healthcare facilities to track blood safety errors and various 
healthcare-associated infection prevention practice methods such as 
healthcare personnel influenza vaccine status and corresponding 
infection control adherence rates.
    NHSN currently has six components: Patient Safety (PS), Healthcare 
Personnel Safety (HPS), Biovigilance (BV), Long-Term Care Facility 
(LTCF), Outpatient Procedure (OPC), and the Dialysis Component. NHSN's 
planned Neonatal Component is expected to launch during the winter of 
2021, and will focus on premature neonates and the healthcare-
associated events that occur as a result of their prematurity. This 
component will be released with one module, which includes Late Onset-
Sepsis (LOS) and Meningitis. LOS and Meningitis are common 
complications of extreme prematurity. These infections result in a 
prolongation of hospital stay, increased cost, and risk of morbidity 
and mortality. The data for this module will be electronically 
submitted, allowing more hospital personnel to be available to care for 
patients and reducing annual burden across healthcare facilities. 
Additionally, LOS data will be utilized for prevention initiatives.
    Data reported under the Patient Safety Component are used to 
determine the magnitude of the healthcare-associated adverse events and 
trends in the rates of events, in the distribution of pathogens, and in 
the adherence to prevention practices. Data will help detect changes in 
the epidemiology of adverse events resulting from new medical therapies 
and changing patient risks. Additionally, reported data is being used 
to describe the epidemiology of antimicrobial use and resistance, and 
to better understand the relationship of antimicrobial therapy to this 
rising problem.
    Under the Healthcare Personnel Safety Component (HPS), protocols 
and data on events--both positive and adverse--are used to determine; 
(1) the magnitude of adverse events in healthcare personnel, and (2) 
compliance with immunization and sharps injuries safety guidelines.
    The Biovigilance (BV) Component collects data on adverse reactions 
and incidents associated with blood transfusions. Data is reported and 
analyzed to provide national estimates of adverse reactions and 
incidents.
    Under the Long-Term Care Facility (LTCF) Component, data is 
captured from skilled nursing facilities. Reporting methods under the 
LTCF component have been created by using forms from the PS Component 
as a model with modifications to specifically address the specific 
characteristics of LTCF residents and the unique data needs of these 
facilities reporting into NHSN. The Respiratory Tract Infection Form 
(RTI), titled ``Denominators for Healthcare Associated Infections 
(HAIs): Respiratory Tract Infections,'' will not to be used by NHSN 
users, but rather as part of an EIP project with 4 EIP sites. The 
purpose of this form is to allow testing prior to introducing a new 
module and forms to NHSN users. The CDC's Epidemiology Research & 
Innovations Branch (ERIB) team will use the form to perform field 
testing of variables to explore the utilization, applicability, and 
data collection burden associated with these variables. This process 
will inform areas of improvement prior to incorporating the new module, 
including protocol, forms, and instructions into NHSN.
    The Dialysis Component offers a simplified user interface for 
dialysis users to streamline their data entry and analyses processes, 
as well as provide options for expanding in the future to include 
dialysis surveillance in settings other than outpatient facilities.
    The Outpatient Procedure Component (OPC) gathers data on the impact 
of infections and outcomes related to operative procedures performed in 
Ambulatory Surgery Centers (ASCs). The OPC is used to monitor two event 
types: Same Day Outcome Measures and Surgical Site Infections (SSIs).
    NHSN has increasingly served as the operating system for HAI 
reporting compliance through legislation established by the states. As 
of April 2020, 36 states, the District of Columbia and the City of 
Philadelphia, Pennsylvania have opted to use NHSN as their primary 
system for mandated reporting. Reporting compliance is completed by 
healthcare facilities in their respective jurisdictions, with emphasis 
on those states and municipalities acquiring varying consequences for 
failure to use NHSN. Additionally, healthcare facilities in five U.S. 
territories (Puerto Rico, American Samoa, the U.S. Virgin Islands, 
Guam, and the Northern Mariana Islands) are voluntarily reporting to 
NHSN. Additional territories are projected to follow with similar use 
of NHSN for reporting purposes.
    NHSN's data is used to aid in the tracking of HAIs and guide 
infection prevention activities/practices that protect patients. The 
Centers for Medicare and Medicaid Services (CMS)and other payers use 
these data to determine incentives for performance at healthcare 
facilities across the U.S. and surrounding territories, and members of 
the public may use some protected data to inform their selection among 
available providers. Each of these parties is dependent on the 
completeness and accuracy of the data. CDC and CMS work closely and are 
fully committed to ensuring complete and accurate reporting, which are 
critical for protecting patients and guiding national, state, and local 
prevention priorities. CMS collects some HAI data and healthcare 
personnel influenza vaccination summary data,

[[Page 53311]]

which is done on a voluntary basis as part of its Fee-for-Service 
Medicare quality reporting programs, while others may report data 
required by a federal mandate. Facilities that fail to report quality 
measure data are subject to partial payment reduction in the applicable 
Medicare Fee-for-Service payment system. CMS links their quality 
reporting to payment for Medicare-eligible acute care hospitals, 
inpatient rehabilitation facilities, long-term acute care facilities, 
oncology hospitals, inpatient psychiatric facilities, dialysis 
facilities, and ambulatory surgery centers. Facilities report HAI data 
and healthcare personnel influenza vaccination summary data to CMS via 
NHSN as part of CMS's quality reporting programs to receive full 
payment.
    Still, many healthcare facilities, even in states without HAI 
reporting legislation, submit limited HAI data to NHSN voluntarily. 
NHSN's data collection updates continue to support the incentive 
programs managed by CMS. For example, survey questions support 
requirements for CMS' quality reporting programs. Additionally, CDC has 
collaborated with CMS on a voluntary National Nursing Home Quality 
Collaborative, which focuses on recruiting nursing homes to report HAI 
data to NHSN and to retain their continued participation.
    NHSN was previously approved in December 2020 for 1,321,991 burden 
hours. The proposed changes in this new ICR include revisions to 10 
data collection forms and no new forms for a total of 86 proposed data 
collection forms. In this Revision, CDC requests OMB approval for an 
estimated 1,718,591 annual burden hours.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of      Avg. burden
               Form number & name                    Number of     responses per   per response    Total burden
                                                    respondents     respondent        (hours)         (hours)
----------------------------------------------------------------------------------------------------------------
57.100 NHSN Registration Form...................           2,000               1            5/60             167
57.101 Facility Contact Information.............           2,000               1           10/60             333
57.103 Patient Safety Component--Annual Hospital           6,765               1           90/60          10,148
 Survey.........................................
57.104 Facility Administrator Change Request                 800               1            5/60              67
 Form...........................................
57.105 Group Contact Information................           1,000               1            5/60              83
57.106 Patient Safety Monthly Reporting Plan....           7,821              12           15/60          23,463
57.108 Primary Bloodstream Infection (BSI)......           5,775               5           38/60          18,288
57.111 Pneumonia (PNEU).........................           1,800               2           30/60           1,800
57.112 Ventilator-Associated Event..............           5,463               8           28/60          20,395
57.113 Pediatric Ventilator-Associated Event                 334               1           30/60             167
 (PedVAE).......................................
57.114 Urinary Tract Infection (UTI)............           6,000               5           20/60          10,000
57.115 Custom Event.............................             600              91           35/60          31,850
57.116 Denominators for Neonatal Intensive Care            1,100              12            4/60             880
 Unit (NICU)....................................
57.117 Denominators for Specialty Care Area                  500              12            5/60             500
 (SCA)/Oncology (ONC)...........................
57.118 Denominators for Intensive Care Unit                5,500              60            5/60          27,500
 (ICU)/Other locations (not NICU or SCA)........
57.120 Surgical Site Infection (SSI)............           6,000               9           35/60          31,500
57.121 Denominator for Procedure................           6,000             602           10/60         602,000
57.122 HAI Progress Report State Health                       55               1           28/60              26
 Department Survey..............................
57.123 Antimicrobial Use and Resistance (AUR)--            2,500              12            5/60           2,500
 Microbiology Data Electronic Upload
 Specification Tables...........................
57.124 Antimicrobial Use and Resistance (AUR)--            2,500              12            5/60           2,500
 Pharmacy Data Electronic Upload Specification
 Tables.........................................
57.125 Central Line Insertion Practices                      500             213           25/60          44,375
 Adherence Monitoring...........................
57.126 MDRO or CDI Infection Form...............             720              11           30/60           3,960
57.127 MDRO and CDI Prevention Process and                 5,500              29           15/60          39,875
 Outcome Measures Monthly Monitoring............
57.128 Laboratory-identified MDRO or CDI Event..           4,800              79           20/60         126,400
57.129 Adult Sepsis.............................              50             250           25/60           5,208
57.135 Late Onset Sepsis/Meningitis Denominator              300               6            5/60             150
 Form: Data Table for monthly electronic upload.
57.136 Late Onset Sepsis/Meningitis Event Form:              300               6            5/60             150
 Data Table for Monthly Electronic Upload.......
57.137 Long-Term Care Facility Component--Annual          17,700               1          120/60          35,400
 Facility Survey................................
57.138 Laboratory-identified MDRO or CDI Event             1,998              24           20/60          15,984
 for LTCF.......................................
57.139 MDRO and CDI Prevention Process Measures            1,998              12           20/60           7,992
 Monthly Monitoring for LTCF....................
57.140 Urinary Tract Infection (UTI) for LTCF...             339              36           35/60           7,119
57.141 Monthly Reporting Plan for LTCF..........            2011              12            5/60           2,011
57.142 Denominators for LTCF Locations..........             339              12           35/60           2,373
57.143 Prevention Process Measures Monthly                   130              12            5/60             130
 Monitoring for LTCF............................
57.150 LTAC Annual Survey.......................             620               1           82/60             847
57.151 Rehab Annual Survey......................           1,340               1           82/60           1,831
57.200 Healthcare Personnel Safety Component                  50               1          480/60             400
 Annual Facility Survey.........................
57.204 Healthcare Worker Demographic Data.......              50             200           20/60           3,333
57.205 Exposure to Blood/Body Fluids............              50              50           60/60           2,500
57.206 Healthcare Worker Prophylaxis/Treatment..              50              30           15/60             375
57.207 Follow-Up Laboratory Testing.............              50              50           15/60             625
57.210 Healthcare Worker Prophylaxis/Treatment-               50              50           10/60             417
 Influenza......................................
57.300 Hemovigilance Module Annual Survey.......             500               1           85/60             708
57.301 Hemovigilance Module Monthly Reporting                500              12           60/60           6,000
 Plan...........................................
57.303 Hemovigilance Module Monthly Reporting                500              12           70/60           7,000
 Denominators...................................
57.305 Hemovigilance Incident...................             500              10           10/60             833

[[Page 53312]]

 
57.306 Hemovigilance Module Annual Survey--Non-              500               1           35/60             292
 acute care facility............................
57.307 Hemovigilance Adverse Reaction--Acute                 500               4           20/60             667
 Hemolytic Transfusion Reaction.................
57.308 Hemovigilance Adverse Reaction--Allergic              500               4           20/60             667
 Transfusion Reaction...........................
57.309 Hemovigilance Adverse Reaction--Delayed               500               1           20/60             167
 Hemolytic Transfusion Reaction.................
57.310 Hemovigilance Adverse Reaction--Delayed               500               2           20/60             333
 Serologic Transfusion Reaction.................
57.311 Hemovigilance Adverse Reaction--Febrile               500               4           20/60             667
 Non-hemolytic Transfusion Reaction.............
57.312 Hemovigilance Adverse Reaction--                      500               1           20/60             167
 Hypotensive Transfusion Reaction...............
57.313 Hemovigilance Adverse Reaction--Infection             500               1           20/60             167
57.314 Hemovigilance Adverse Reaction--Post                  500               1           20/60             167
 Transfusion Purpura............................
57.315 Hemovigilance Adverse Reaction--                      500               1           20/60             167
 Transfusion Associated Dyspnea.................
57.316 Hemovigilance Adverse Reaction--                      500               1           20/60             167
 Transfusion Associated Graft vs. Host Disease..
57.317 Hemovigilance Adverse Reaction--                      500               1           20/60             167
 Transfusion Related Acute Lung Injury..........
57.318 Hemovigilance Adverse Reaction--                      500               2           20/60             333
 Transfusion Associated Circulatory Overload....
57.319 Hemovigilance Adverse Reaction--Unknown               500               1           20/60             167
 Transfusion Reaction...........................
57.320 Hemovigilance Adverse Reaction--Other                 500               1           20/60             167
 Transfusion Reaction...........................
57.400 Outpatient Procedure Component--Annual                700               1           10/60             117
 Facility Survey................................
57.401 Outpatient Procedure Component--Monthly               700              12           15/60           2,100
 Reporting Plan.................................
57.402 Outpatient Procedure Component Same Day               200               1           40/60             133
 Outcome Measures...............................
57.403 Outpatient Procedure Component--Monthly               200             400           40/60          53,333
 Denominators for Same Day Outcome Measures.....
57.404 Outpatient Procedure Component--SSI                   700             100           40/60          46,667
 Denominator....................................
57.405 Outpatient Procedure Component--Surgical              700               5           40/60           2,333
 Site (SSI) Event...............................
57.500 Outpatient Dialysis Center Practices                7,200               1           12/60           1,440
 Survey.........................................
57.501 Dialysis Monthly Reporting Plan..........           7,200              12            5/60           7,200
57.502 Dialysis Event...........................           7,200              30           25/60          90,000
57.503 Denominator for Outpatient Dialysis......           7,200              30           10/60           36000
57.504 Prevention Process Measures Monthly                 1,730              12           75/60          25,950
 Monitoring for Dialysis........................
57.505 Dialysis Patient Influenza Vaccination...             615              50           10/60           5,125
57.506 Dialysis Patient Influenza Vaccination                615               5           10/60             513
 Denominator....................................
57.507 Home Dialysis Center Practices Survey....             430               1           30/60             215
Weekly Healthcare Personnel Influenza                        125              52           60/60           6,500
 Vaccination Cumulative Summary for Non-Long-
 Term Care Facilities...........................
Weekly Healthcare Personnel Influenza                      1,200              52           60/60          62,400
 Vaccination Cumulative Summary for Long-Term
 Care Facilities................................
Weekly Resident Influenza Vaccination Cumulative           2,500              52           60/60         130,000
 Summary for Long-Term Care Facilities..........
Annual Healthcare Personnel Influenza                      5,000               1          120/60          10,000
 Vaccination Summary............................
                                                 ---------------------------------------------------------------
    Total.......................................  ..............  ..............  ..............       1,718,591
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2021-20846 Filed 9-24-21; 8:45 am]
BILLING CODE 4163-18-P